» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
- Indigenous Health in Medicine Program Manager looks to build and strengthen connections
- Researchers from Dalhousie and IWK Health Centre Receive $4.8 Million in Funding from Genome Canada
- Dal contributes to first ever Lancet Child and Adolescent Health Commission
- Molly Appeal: Maritime researchers pioneering technology in early diagnosis of Alzheimer's disease
- Excluding pregnant women from COVID‑19 vaccine trials puts their health at risk
- Partnering to improve health outcomes at patient and population levels across the Maritimes
- Making Space, Elevating Voices: Dal Community Members take part in Scholar Strike
- Program provides solution for keeping doctors in rural areas